Mumbai, Nov 30 (NationPress) ChrysCapital has reinforced its commitment to India's growth trajectory by successfully raising an unprecedented $2.2 billion for its latest investment fund, marking the largest private equity corpus ever gathered by a firm focused solely on India.

This fund's size surpasses its predecessor, which was $1.35 billion, by over 60 percent, highlighting the increasing confidence of both global and local investors in India's economic potential, especially during a challenging fundraising environment worldwide.

The firm intends to allocate capital from this new fund over the next three to four years, targeting sectors such as healthcare, financial services, consumer goods, and enterprise technology, all of which are experiencing robust long-term demand in India.

This record-breaking fundraising occurs amid a flourishing landscape for private equity and venture capital in India.

Investments have surged to $26 billion in the first nine months of 2025, the highest in three years.

In the July–September quarter alone, the industry witnessed $5.7 billion flowing into 301 deals.

ChrysCapital’s new fund has attracted 30 new global investors from regions including Japan, the Middle East, Europe, and the United States.

Notably, around 15 percent of the total came from Indian institutional investors and family offices, indicating a growing local interest in private market prospects.

Recent growth has been primarily driven by sectors like financial services, e-commerce, and technology, bolstered by India's 6.5 percent GDP growth and progressive policy reforms.

ChrysCapital has a proven track record that enhances investor trust. Since its inception in 1999, the firm has raised $8.5 billion across 10 funds, invested $5.5 billion in 110 companies, and achieved $7.8 billion in returns from 80 exits, averaging a 3x return on investment.

Its investments in renowned companies like Lenskart, Dream11, FirstCry, and the National Stock Exchange showcase its focus on scalable and profitable ventures.

The new fund is anticipated to foster expansion, innovation, and job creation across high-potential sectors.

ChrysCapital plans to execute 15–16 investments ranging from $75–200 million each, favoring majority stakes in resilient areas such as pharmaceuticals and manufacturing.

As India's middle class expands and digital adoption accelerates, fresh capital is set to enhance consumption and productivity.

Sectors such as healthcare and fintech are poised for substantial job creation, bolstered by investments in firms like KIMS Hospitals.

This fundraising initiative will also strengthen India's capital markets by enabling more private equity-backed companies to pursue IPOs, a trend that is on the rise.

The heightened participation of Indian investors indicates a maturing financial ecosystem where local wealth is reinvested into domestic businesses, reducing reliance on foreign capital amidst global uncertainties.

Nonetheless, challenges remain. Global trade tensions, geopolitical instability, and volatile inflation could hinder deal-making and create valuation discrepancies.

Moreover, elevated interest rates may impact capital-intensive sectors like manufacturing. While exits have decelerated earlier this year, opportunities continue to emerge through open-market deals and new listings.

Policy shifts, including GST revisions and progress on a potential US-India trade agreement, will also affect future investment flows.